The influence of protons and zinc ions on the steady-state inactivation of Kv1.3 potassium channels.
Using the whole-cell patch-clamp technique, we investigated the influence of extracellular pH and zinc ions (Zn(2+)) on the steady-state inactivation of Kv1.3 channels expressed in human lymphocytes. The obtained data showed that lowering the extracellular pH from 7.35 to 6.8 shifted the inactivation midpoint (V(i)) by 17.4 +/- 1.12 mV (n = 6) towards positive membrane potentials. This shift was statistically significant (p < 0.05). Applying 100 microM Zn(2+) at pH 6.8 further shifted the Vi value by 16.55 +/- 1.80 mV (n = 6) towards positive membrane potentials. This shift was also statistically significant (p < 0.05). The total shift of the Vi by protons and Zn(2+) was 33.95 +/- 1.90 mV (n = 6), which was significantly higher (p < 0.05) than the shift caused by Zn(2+) alone. The Zn(2+)-induced shift of the V(i) at pH 6.8 was almost identical to the shift at pH = 7.35. Thus, the proton-and Zn(2+)-induced shifts of the V(i) value were additive. The steady-state inactivation curves as a function of membrane voltage were compared with the functions of the steady-state activation. The total shift of the steady-state inactivation was almost identical to the total shift of the steady-state activation (32.01 +/- 2.10 mV, n = 10). As a result, the "windows" of membrane potentials in which the channels can be active under physiological conditions were also markedly shifted towards positive membrane potentials. The values of membrane voltage and the normalised chord conductance corresponding to the points of intersection of the curves of steady-state activation and inactivation were also calculated. The possible physiological significance of the observed modulatory effects is discussed herein.
Teisseyre
Andrzej
A
Department of Biophysics, Wrocław Medical University, Wrocław, Poland. ateiss@biofiz.am.wroc.pl
Mozrzymas
Jerzy W
JW
D006801:Humans; D006863:Hydrogen-Ion Concentration; D015640:Ion Channel Gating / Q000187:drug effects*; D007700:Kinetics; D051664:Kv1.3 Potassium Channel / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011522:Protons; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D015032:Zinc / Q000494:pharmacology*
D051664:Kv1.3 Potassium Channel; D011522:Protons; D015032:Zinc